BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7838482)

  • 1. Comparative ototoxicity of cisplatin during acute and chronic treatment.
    Saito T; Aran JM
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):315-20. PubMed ID: 7838482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ototoxicity of the new platinum anticancer agent TRK-710 in comparison with cisplatin.
    Saito T; Manabe Y; Saito H
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):250-5. PubMed ID: 8587776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar pharmacokinetics and differential ototoxicity after administration with cisplatin and transplatin in guinea pigs.
    Saito T; Zhang ZJ; Yamada T; Yamamoto T; Shibamori Y; Saito H
    Acta Otolaryngol; 1997 Jan; 117(1):61-5. PubMed ID: 9039483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].
    Liao YJ; Tang H
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):266-9. PubMed ID: 14628479
    [No Abstract]   [Full Text] [Related]  

  • 5. X-ray microanalysis and ion microscopy of guinea pig cochlea and kidney after cisplatin treatment.
    Saito T; Aran JM
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):310-4. PubMed ID: 7838481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of coenzyme A on outer hair cells in cisplatin ototoxicity: functional and ultrastructural study.
    Fernández-Cervilla F; Martínez-Martínez M; Fernández-Segura E; Cañizares-García FJ; Crespo-Ferrer PV
    Histol Histopathol; 2017 Feb; 32(2):171-176. PubMed ID: 27121633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.
    Wolters FL; Klis SF; de Groot JC; Hamers FP; Prieskorn DM; Miller JM; Smoorenburg GF
    Hear Res; 2003 May; 179(1-2):53-61. PubMed ID: 12742238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea.
    Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
    Hear Res; 2000 Jun; 144(1-2):135-46. PubMed ID: 10831872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
    Schweitzer VG
    Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perilymphatic application of cisplatin over several days in albino guinea pigs: dose-dependency of electrophysiological and morphological effects.
    O'Leary SJ; Klis SF; de Groot JC; Hamers FP; Smoorenburg GF
    Hear Res; 2001 Apr; 154(1-2):135-45. PubMed ID: 11423224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs.
    Saito T; Manabe Y; Honda N; Yamada T; Yamamoto T; Saito H
    Scanning Microsc; 1995 Mar; 9(1):271-80; discussion 280-1. PubMed ID: 8553022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of toxicokinetics in xylene-induced ototoxicity in the rat and guinea pig.
    Gagnaire F; Marignac B; Blachère V; Grossmann S; Langlais C
    Toxicology; 2007 Mar; 231(2-3):147-58. PubMed ID: 17210216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of the neurotrophic ACTH(4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin.
    de Groot JC; Hamers FP; Gispen WH; Smoorenburg GF
    Hear Res; 1997 Apr; 106(1-2):9-19. PubMed ID: 9112103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
    Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
    Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ozone (O
    Koçak HE; Taşkın Ü; Aydın S; Oktay MF; Altınay S; Çelik DS; Yücebaş K; Altaş B
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4153-4159. PubMed ID: 27221387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronotolerance for cisplatin ototoxicity in the rat.
    Bielefeld EC; Markle A; DeBacker JR; Harrison RT
    Hear Res; 2018 Dec; 370():16-21. PubMed ID: 30253329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibitor suppresses the ototoxic side effect of cisplatin in guinea pigs.
    Watanabe KI; Hess A; Bloch W; Michel O
    Anticancer Drugs; 2000 Jun; 11(5):401-6. PubMed ID: 10912957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin and cisplatin ototoxicity in guinea pigs.
    Taudy M; Syka J; Popelár J; Ulehlová L
    Audiology; 1992; 31(5):293-9. PubMed ID: 1449432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.